SEMAGLUTIDE (OZEMPIC, WEGOVY)
GLP-1 receptor agonist. Once-weekly injection. Suppresses appetite, slows gastric emptying, improves insulin sensitivity.
Semaglutide. Tirzepatide. Physician-supervised medical weight loss in Las Vegas. Average 15–20% body weight loss in clinical trials — sustained with proper protocols and ongoing monitoring.
GLP-1 medications (semaglutide, tirzepatide) are the most effective weight-loss medications ever developed. Clinical trials show 15-20% body weight reduction — comparable to bariatric surgery, without the surgery.
But the medication is one piece. The other pieces are dose titration, side-effect management, body composition tracking, lab monitoring, and the lifestyle work that makes the loss permanent. That's what physician supervision means.
Take our quick assessment to find out if medical weight loss is right for you.
BMI = weight (kg) / height (m)². Or estimate based on your weight.
We offer semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) for medical weight loss at our Las Vegas office, prescribed and monitored by our physicians.
Clinical trials show average weight loss of 15-20% of body weight with GLP-1 medications when combined with diet and lifestyle changes. Individual results vary based on medication, dosage, and adherence.
No, our medical weight loss program is available to both members and non-members at our Las Vegas practice.
Semaglutide (Ozempic/Wegovy) targets one hormone receptor (GLP-1), while tirzepatide (Mounjaro/Zepbound) targets two receptors (GLP-1 and GIP). Both are effective; your Parker Medical physician will recommend the best option for your health profile.
Most patients see significant results within 3-6 months. Treatment duration depends on your goals, response to medication, and your physician's recommendations. We provide ongoing monitoring and dosage adjustments.
Schedule a consultation. Insurance often covers GLP-1 medications when prescribed appropriately.
Book Your ConsultationOr call (702) 778-2204